We increased the concentration gradient from the standard 10 μM and observed that a single treatment with Nutlin-3 did not show significant changes in TP53-mutated HCC cell lines, as assessed by Annexin-V and 7-AAD double staining. The gene discussed is ANXA5; the disease is hepatocellular carcinoma.